134 related articles for article (PubMed ID: 21843632)
1. Tat-enhanced delivery of metallothionein can partially prevent the development of diabetes.
Park L; Min D; Kim H; Chung HY; Lee CH; Park IS; Kim Y; Park Y
Free Radic Biol Med; 2011 Nov; 51(9):1666-74. PubMed ID: 21843632
[TBL] [Abstract][Full Text] [Related]
2. The combination of metallothionein and superoxide dismutase protects pancreatic β cells from oxidative damage.
Park L; Min D; Kim H; Park J; Choi S; Park Y
Diabetes Metab Res Rev; 2011 Nov; 27(8):802-8. PubMed ID: 22069263
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 Tat-mediated protein transduction of Cu,Zn-superoxide dismutase into pancreatic beta cells in vitro and in vivo.
Eum WS; Choung IS; Li MZ; Kang JH; Kim DW; Park J; Kwon HY; Choi SY
Free Radic Biol Med; 2004 Aug; 37(3):339-49. PubMed ID: 15223067
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulation of cell-penetrating tat-metallothionein for successful outcome of xenotransplanted pancreatic islet.
Kim MJ; Hwang YH; Kim YH; Lee DY
J Drug Target; 2017 Apr; 25(4):350-359. PubMed ID: 27829285
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic resistance of hypodermically transplanted pancreatic islets by using cell-absorbable antioxidant Tat-metallothionein.
Jung HS; Lim KS; Kim MJ; Hwang YH; Yoo C; Lee YK; Kim YH; Lee DY
J Control Release; 2013 Dec; 172(3):1092-101. PubMed ID: 24103814
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of diabetic neuropathy by TAT-mediated enhanced delivery of metallothionein and SOD.
Min D; Kim H; Park L; Kim TH; Hwang S; Kim MJ; Jang S; Park Y
Endocrinology; 2012 Jan; 153(1):81-91. PubMed ID: 22128026
[TBL] [Abstract][Full Text] [Related]
7. Tat-biliverdin reductase A protects INS-1 cells from human islet amyloid polypeptide-induced cytotoxicity by alleviating oxidative stress and ER stress.
Lee SJ; Kang HK; Eum WS; Park J; Choi SY; Kwon HY
Cell Biol Int; 2017 May; 41(5):514-524. PubMed ID: 28198575
[TBL] [Abstract][Full Text] [Related]
8. Preparation and functional analysis of recombinant protein transduction domain-metallothionein fusion proteins.
Lim KS; Won YW; Park YS; Kim YH
Biochimie; 2010 Aug; 92(8):964-70. PubMed ID: 20403412
[TBL] [Abstract][Full Text] [Related]
9. Dual Opposing Roles of Metallothionein Overexpression in C57BL/6J Mouse Pancreatic β-Cells.
Chen S; Han J; Liu Y
PLoS One; 2015; 10(9):e0137583. PubMed ID: 26335571
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of protein transduction domain-metallothionein fusion proteins against hypoxia- and oxidative stress-induced apoptosis in an ischemia/reperfusion rat model.
Lim KS; Cha MJ; Kim JK; Park EJ; Chae JW; Rhim T; Hwang KC; Kim YH
J Control Release; 2013 Aug; 169(3):306-12. PubMed ID: 23391442
[TBL] [Abstract][Full Text] [Related]
11. Dual-mode enhancement of metallothionein protein with cell transduction and retention peptide fusion.
Lim KS; Lim MH; Won YW; Kim JK; Kang YC; Park EJ; Chae JW; Kim SM; Ryu SE; Pak YK; Kim YH
J Control Release; 2013 Oct; 171(2):193-200. PubMed ID: 23871961
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of Tat-DJ-1 protein against streptozotocin-induced diabetes in a mice model.
Yeo H; Yeo EJ; Shin MJ; Choi YJ; Lee CH; Kwon HY; Kim DW; Eum WS; Choi SY
BMB Rep; 2018 Jul; 51(7):362-367. PubMed ID: 29936932
[TBL] [Abstract][Full Text] [Related]
13. An HIV-1 tat-autoantigen fusion protein suppresses insulitis in NOD mice.
Kim TG; Yu J; Hough J; Henderson D; Langridge WH
Mol Biotechnol; 2005 Jul; 30(3):221-9. PubMed ID: 15988047
[TBL] [Abstract][Full Text] [Related]
14. Proteins linked to a protein transduction domain efficiently transduce pancreatic islets.
Embury J; Klein D; Pileggi A; Ribeiro M; Jayaraman S; Molano RD; Fraker C; Kenyon N; Ricordi C; Inverardi L; Pastori RL
Diabetes; 2001 Aug; 50(8):1706-13. PubMed ID: 11473028
[TBL] [Abstract][Full Text] [Related]
15. Tat-ATOX1 inhibits streptozotocin-induced cell death in pancreatic RINm5F cells and attenuates diabetes in a mouse model.
Ahn EH; Kim DW; Shin MJ; Ryu EJ; Yong JI; Chung SY; Cha HJ; Kim SJ; Choi YJ; Kim DS; Cho SW; Lee K; Cho YS; Kwon HY; Park J; Eum WS; Choi SY
Int J Mol Med; 2016 Jul; 38(1):217-24. PubMed ID: 27222268
[TBL] [Abstract][Full Text] [Related]
16. Bezafibrate on lipids and glucose metabolism in obese diabetic Otsuka Long-Evans Tokushima fatty rats.
Jia D; Yamamoto M; Otani M; Otsuki M
Metabolism; 2004 Apr; 53(4):405-13. PubMed ID: 15045684
[TBL] [Abstract][Full Text] [Related]
17. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
18. The combined inducible nitric oxide synthase inhibitor and free radical scavenger guanidinoethyldisulfide prevents multiple low-dose streptozotocin-induced diabetes in vivo and interleukin-1beta-induced suppression of islet insulin secretion in vitro.
Mabley JG; Southan GJ; Salzman AL; Szabó C
Pancreas; 2004 Mar; 28(2):E39-44. PubMed ID: 15028959
[TBL] [Abstract][Full Text] [Related]
19. Diabetes Mellitus induces alterations in metallothionein protein expression and metal levels in the testis and liver.
Gu Y; Lian X; Sun W; Gao B; Fu Y
J Int Med Res; 2018 Jan; 46(1):185-194. PubMed ID: 28760087
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of metallothionein in pancreatic beta-cells reduces streptozotocin-induced DNA damage and diabetes.
Chen H; Carlson EC; Pellet L; Moritz JT; Epstein PN
Diabetes; 2001 Sep; 50(9):2040-6. PubMed ID: 11522669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
